A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer This study investigates a new gel called **ENERGI-F703** for people with **diabetic foot ulcers**. These ulcers are sores that don't heal well because of diabetes. The study is "randomized," meaning participants are randomly chosen to receive either the gel or a placebo (a substance with no active drug). It will be conducted at multiple centers, ensuring diverse participation. The study will last up to **31 weeks**, starting with a **screening visit** for 2-3 weeks, followed by a 16-week treatment phase where neither participants nor researchers will know who receives the gel. Finally, participants will have a 12-week follow-up to monitor safety.

• Participants must be at least 18 years old and have a diabetic foot ulcer classified as Wagner Grade 1 or 2.
• The study requires regular visits and monitoring to ensure the safety and effectiveness of the treatment.
• There are specific health criteria for eligibility, including diabetes management and ulcer conditions.

If you have a diabetic foot ulcer and meet the criteria, this research could help advance treatment options. Speak with your doctor to see if joining is right for you.